About Lanthio Pharma
Lanthio Pharma is a company based in Groningen (Netherlands) founded in 2010 was acquired by MorphoSys in May 2015.. Lanthio Pharma has raised $6.27 million across 3 funding rounds from investors including MorphoSys, Rijksdienst voor Ondernemend Nederland and BioGeneration Ventures.
- Headquarter Groningen, Netherlands
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lanthio Pharma
Lanthio Pharma has successfully raised a total of $6.27M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4.93 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $4.9M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2014 | Amount | Debt – Conventional - Lanthio Pharma | Valuation |
investors |
|
| Nov, 2012 | Amount | Series A - Lanthio Pharma | Valuation | BioGeneration Ventures , MorphoSys |
|
| Jun, 2011 | Amount | Seed - Lanthio Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lanthio Pharma
Lanthio Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include MorphoSys, Rijksdienst voor Ondernemend Nederland and BioGeneration Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science focused VC firm investing in startups in Europe
|
Founded Year | Domain | Location | |
|
AI, deeptech, and healthcare tech companies are funded by Inkef.
|
Founded Year | Domain | Location | |
|
Provider of subsidies and financial support for businesses
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lanthio Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lanthio Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lanthio Pharma Comparisons
Competitors of Lanthio Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lanthio Pharma
Frequently Asked Questions about Lanthio Pharma
When was Lanthio Pharma founded?
Lanthio Pharma was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Lanthio Pharma located?
Lanthio Pharma is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
Is Lanthio Pharma a funded company?
Lanthio Pharma is a funded company, having raised a total of $6.27M across 3 funding rounds to date.
What does Lanthio Pharma do?
Lanthio Pharma is committed to developing and commercializing therapeutic peptides against difficult to target receptors (e.g. GPCRs). With its proprietary LanthioPep technology, the company is generating peptide drugs that are markedly enhanced for stability and selectivity. Company is building a growing pipeline of stabilized, receptor specific lanthipeptides with the potential for treatment of fibrosis, heart failure and multiple sclerosis. Pipeline includes LP2 for diabetic nephropathy, lanthi-apelin for heart failure, lanthi-galani for multiple sclerosis and pancyte (indication is confidential). company was acquired by morphosys in 2015.
Who are Lanthio Pharma's investors?
Lanthio Pharma has 4 investors. Key investors include MorphoSys, Rijksdienst voor Ondernemend Nederland, BioGeneration Ventures, and Inkef.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.